CARDIOVASCULAR DRUG USE IN PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER

被引：0
|
作者：
Laursen, Thomas M. [1 ]
Mortensen, Preben B. [1 ]
MacCabe, James H. [2 ]
Cohen, Dan [3 ]
Gasse, Christiane [1 ]
机构：
[1] Aarhus Univ, Aarhus, Denmark
[2] Inst Psychiat, Dept Psychosis Studies, London, England
[3] Mental Hlth Org North Holland North, Heerhugowaard, Netherlands
来源：
SCHIZOPHRENIA RESEARCH | 2012年 / 136卷
关键词：
D O I：
10.1016/S0920-9964(12)70665-5
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
93
引用
收藏
页码：S219 / S219
页数：1
相关论文
共 50 条
  • [1] Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: a Danish population-based study
    Laursen, T. M.
    Mortensen, P. B.
    MacCabe, J. H.
    Cohen, D.
    Gasse, C.
    PSYCHOLOGICAL MEDICINE, 2014, 44 (08) : 1625 - 1637
  • [2] CARDIOVASCULAR DISEASE RISK IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER
    Rodevand, Linn
    Steen, Nils Eiel
    Quintana, Daniel
    Reponen, Elina Johanna
    Morch, Ragni Helene
    Lunding, Synve Hoffart
    Iversen, Trude
    Lagerberg, Trine V.
    Melle, Ingrid
    Andreassen, Ole A.
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S362 - S362
  • [3] Cardiovascular Risk for Patients With and Without Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder
    Rossom, Rebecca C.
    Hooker, Stephanie A.
    O'Connor, Patrick J.
    Crain, A. Lauren
    Sperl-Hillen, Joann M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (06):
  • [4] METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PATIENTS WITH SCHIZOPHRENIA, BIPOLAR DISORDER AND SCHIZOAFFECTIVE DISORDER
    Munoz-Calero Franco, Paloma
    Sanchez Sanchez, Blanca
    Rodriguez Criado, Natalia
    Pinilla Santos, Berta
    Bravo Herrero, Sandra
    Cruz Fourcade, Jose Fernando
    Martin Aragon, Ruben
    NUTRICION HOSPITALARIA, 2015, 32 (06) : 2715 - 2717
  • [5] DRUG-ABUSE IN SCHIZOPHRENIA AND BIPOLAR DISORDER
    MILLER, FT
    BUSCH, F
    TANENBAUM, JH
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 1989, 15 (03): : 291 - 295
  • [6] Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, Schizoaffective disorder, and bipolar disorder
    Kilbourne, Amy M.
    Brar, Jaspreet S.
    Drayer, Rebecca A.
    Xu, Xiangyan
    Post, Edward P.
    PSYCHOSOMATICS, 2007, 48 (05) : 412 - 417
  • [7] Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder
    Kilbourne, Amy M.
    Post, Edward P.
    Bauer, Mark S.
    Zeber, John E.
    Copeland, Laurel A.
    Good, Chester B.
    Pincus, Harold Alan
    JOURNAL OF AFFECTIVE DISORDERS, 2007, 102 (1-3) : 145 - 151
  • [8] Efficacy and tolerability of depot antipsychotic use in patients with schizophrenia and bipolar disorder
    Inanc, Leman
    Ozdemir, Aysun Demir
    Gulec, Huseyin
    Semiz, Umit Basar
    CUKUROVA MEDICAL JOURNAL, 2018, 43 : 38 - 43
  • [9] Comparison of Patients with Schizophrenia, Bipolar Disorder, and Substance Use Disorder in Terms of Family Burden
    Kahya, Yalcin
    Erdogan, Ali
    Onder, Arif
    Kulaksizoglu, Burak
    Kuloglu, Mehmet Murat
    ADDICTA-THE TURKISH JOURNAL ON ADDICTIONS, 2022, 9 (01): : 16 - 22
  • [10] Comparison of neurocognition between drug-free patients with schizophrenia and bipolar disorder
    Tam, WCC
    Liu, ZN
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2004, 192 (07) : 464 - 470
12345